BISICHEM

bisichem-logo

BiSiChem is a biotechnology company that focuses on the drug discovery and development field.

#Website #More

BISICHEM

Industry:
Biopharma Biotechnology Life Science

Founded:
2017-08-01

Address:
Bundangdong, Kyonggi-do, South Korea

Country:
South Korea

Website Url:
http://www.bisichem.com

Status:
Active

Contact:
82-31-698-3772

Email Addresses:
[email protected]

Technology used in webpage:
SPF SSL By Default LetsEncrypt IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare CDN CodeMirror


Official Site Inspections

http://www.bisichem.com

  • Host name: 203.245.44.63
  • IP address: 203.245.44.63
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "BiSiChem"

BiSiChem

BiSiChem is a leading biotech company that focused on the discovery and development of innovative therapeutic drugs on immuno-oncology, targeted therapy and neuro-degenerative โ€ฆSee details»

BiSiChem - Crunchbase Company Profile & Funding

BiSiChem is a biotechnology company that focuses on the drug discovery and development field. BiSiChem invents drugs that are either first-in-class or โ€ฆSee details»

BiSiChem Company Profile 2024: Valuation, Funding

Operator of a biotechnology company intended to discover molecule drug targets for immuno-oncology-targeted cancer and CNS therapy.See details»

BiSiChem - VentureRadar

DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and โ€ฆSee details»

BiSiChem - Products, Competitors, Financials, Employees, โ€ฆ

Bisichem BioTech startups in Korea โ€“ BiSiChem is a cancer treatment therapy developer that was founded in 2017. They develop top-of-the-line cancer therapies. More specifically the โ€ฆSee details»

BiSiChem - Company Profile - Tracxn

Nov 14, 2024 BisiChem is developing small molecule immuno-oncology & targeted therapeutics for cancer treatment. The lead candidate is a selective RAF family inhibitor which showed low โ€ฆSee details»

BiSiChem - Funding, Financials, Valuation & Investors - Crunchbase

BiSiChem is a biotechnology company that focuses on the drug discovery and development field.See details»

BiSiChem Asset Profile - Preqin

Based in Seongnam, South Korea, and founded in 2017, BiSiChem is a biotechnology company that focuses on the research and development of novel drugs for various therapeutical areas. โ€ฆSee details»

Bisichem - Overview, News & Similar companies | ZoomInfo.com

Bisichem is a company that operates in the Internet industry. It employs 11-20 people and has $1M-$5M of revenue. Is this data correct? View contact profiles from Bisichem. Popular โ€ฆSee details»

BiSiChem - Crunchbase

BiSiChem is a biotechnology company that focuses on the drug discovery and development field.See details»

BiSiChem

Bisichem: 2021-03-18: 1 ์‹ ์ƒ ๋ฐ”์ด์˜ค๋ฒค์ฒ˜ '๋น„์”จ์ผ' ๊ตญ๋‚ด ์ฒซ ์š”์ฆˆ๋งˆํŽ€๋“œ ํˆฌ์ž ์œ ์น˜ : bisichem: 2021-03-18: 5F, Building 1, Pangyo-ro 289beon-gil 20, Bundang-gu, Seongnam-si, Gyeonggi-do, โ€ฆSee details»

BiSiChem

BiSiChem: 2021-03-18: 20 ์ œ3์ž๋ฐฐ์ • ์œ ์ƒ์ฆ์ž ์‹ ์ฃผ๋ฐœํ–‰ ๊ณต๊ณ  : BiSiChem: 2021-03-18: 19 ์ž„์‹œ์ฃผ์ฃผ์ดํšŒ ์†Œ์ง‘์„ ์œ„ํ•œ ๊ธฐ์ค€์ผ ๋ฐ ์ฃผ์‹๋ช…์˜๊ฐœ์„œ ์ •์ง€ ๊ณต๊ณ  : BiSiChem: 2021-03-18 1 2 3 5F, โ€ฆSee details»

BSC-4101 - Drug Targets, Indications, Patents - Synapse

BSC-4101, Initially developed by BiSiChem Co. Ltd., Now, its global highest R&D status is Discovery, Active Org.: BiSiChem Co. Ltd.. ... Active Organization. BiSiChem Co. Ltd. Inactive โ€ฆSee details»

BiSiChem Co. Ltd.

ไบ†่งฃBiSiChem Co. Ltd. (BiSiChem Co. Ltd.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„2็ฏ‡ๆ–ฐ้—ป๏ผŒ็–พ็—…้ข†ๅŸŸ:็ฅž็ป็ณป็ปŸ็–พ็—…๏ผŒๅ…็–ซ็ณป็ปŸ็–พ็—…๏ผŒๅ†…ๅˆ†ๆณŒไธŽไปฃ่ฐข็–พ็—…๏ผŒๆŠ€ๆœฏๅนณๅฐ:ๅฐๅˆ†ๅญๅŒ– โ€ฆSee details»

BSC 1401 - AdisInsight - Springer

31 Dec 2019 BiSiChem has a patent pending for BSC 1401 with the USPTO (BiSiChem pipeline, June 2023) You need to be a logged in or subscribed to view this content Request demo. If โ€ฆSee details»

Series B - BiSiChem - 2019-04-15 - Crunchbase

Organization Name . BiSiChem . Announced Date Apr 15, 2019; Funding Type ...See details»

BiSiChem - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. BiSiChem . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 9. Monthly Visits 30. ...See details»

BSC 1201 - AdisInsight - Springer

27 Jun 2023 BiSiChem files a patent related to BSC 1201 (BiSiChem pipeline, June 2023) 27 Jun 2023 Preclinical trials in Cancer in South Korea ... If your organization or you do not have a โ€ฆSee details»

BSC-4201 - Drug Targets, Indications, Patents - Synapse - Patsnap

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»

BSC 1101 - AdisInsight

27 Jun 2023 Early research in Pain in South Korea (unspecified route) before June 2023 (BiSiChem pipeline, ... If your organization or you do not have a subscription, try one of the โ€ฆSee details»